FDA Increases Existing Warnings on Fosamax, Actonel & Boniva

Get Legal Help Today

 Secured with SHA-256 Encryption

Jeffrey Johnson is a legal writer with a focus on personal injury. He has worked on personal injury and sovereign immunity litigation in addition to experience in family, estate, and criminal law. He earned a J.D. from the University of Baltimore and has worked in legal offices and non-profits in Maryland, Texas, and North Carolina. He has also earned an MFA in screenwriting from Chapman Univer...

Full Bio →

Written by

UPDATED: Feb 5, 2020

Advertiser Disclosure

It’s all about you. We want to help you make the right legal decisions.

We strive to help you make confident insurance and legal decisions. Finding trusted and reliable insurance quotes and legal advice should be easy. This doesn’t influence our content. Our opinions are our own.

Editorial Guidelines: We are a free online resource for anyone interested in learning more about legal topics and insurance. Our goal is to be an objective, third-party resource for everything legal and insurance related. We update our site regularly, and all content is reviewed by experts.

Osteoporosis drugs Actonel, Fosamax and Boniva already contain numerous warnings about serious side effects. Find out why the FDA is now adding more about femur fractures, requiring manufacturers to distribute consumer guides and asking doctors to reassess whether keeping patients on these dangerous drugs on a long term basis is safe.

FDA Gets Tougher About Fosamax Side Effects

The U.S. Food & Drug Administration (FDA) is getting tougher about bisphosphonate drugs – commonly prescribed to prevent or treat osteoporosis in postmenopausal women – such as Warner Chilcott’s Actonel, Merck & Co’s Fosamax (alendronate), Roche’s Boniva and Novartis’ Reclast. That’s certainly not hard to understand as these drugs have been linked to a variety side effects such as ONJ (osteocronosis of the jaw or jaw bone death), esophageal cancer and femur fractures.

Short of pulling these drugs off the market, the FDA is increasing warnings about Fosamax side effects – specifically by informing consumers that there is a risk of atypical fractures of the thigh, known as subtrochanteric and diaphyseal femur fractures. These fractures often occur with little to no trauma and may come after a period of dull, aching pain in the thigh or the groin.

The FDA says that it will: Require manufacturers to distribute consumer-friendly guides with every bisphosphonate prescription to make sure that patients fully understand bisphosphonate side effects; and ask doctors to reassess whether patients should continue taking bisphosphonate drugs after five years or more. It’s the latter that is causing many patients to take what’s referred to as a “drug holiday.”

Get Legal Help Today

Find the right lawyer for your legal issue.

 Secured with SHA-256 Encryption

Is Taking A Drug Holiday Right For You?

Although bisphosphonates are supposed to stop the bone-thinning process by interfering with the way that the human body breaks down bone cells, many doctors believe that this process may actually cause an increase in fractures – especially when used long term.

In fact, Fosamax injury lawyers say that long-term bisphosphonate use can result in severe over-suppression of bone turnover in the femur sub-trochanteric region. They say that “micro-cracks” in the bone are unable to heal and eventually result in these “low energy” or “spontaneous” femur fractures.

Should You File A Fosamax Lawsuit?

If you’ve been injured by Fosamax or another dangerous bisphosphonate drug, contact a Fosamax attorney today to find out more about the Fosamax litigation which is currently consolidated in New Jersey and determine if filing a Fosamax lawsuit is in your best interests.

Get Legal Help Today

Find the right lawyer for your legal issue.

 Secured with SHA-256 Encryption